Abstract: The present invention relates to a combination of inhibitory nucleic acid agents directed at a combination of miRNAs for treatment of heart failure. The combination of inhibited miRNAs comprises one of the groups selected from miR-1a, and miR-15b, or miR-1a, miR-15b and miR-27b, or miR-1a, miR-27b and miR-34a. The combinatorial inhibition of these miRNAs is shown to increase cardiomyocyte proliferation.

Abstract: A body fluid leakage detection aqueous composition, for use e.g. in intraoperative pancreatic fluid leakage detection. The composition comprises a gelling agent, increasing the viscosity of the composition, and buffering species, the composition thereby being buffered. The gelling agent is cross-linked ?-glucan microspheres. Further, the composition comprises a pH-indicator. The pH of the composition is at least 0.1 pH units lower, or higher, than a pKa of the pH-indicator.

Abstract: Provided herein are methods and compositions related to treating motor neuron diseases, such as ALS, in a subject by administering to the subject (e.g., orally administering to the subject) a composition comprising nicotinamide riboside and/or pterostilbene.

Abstract: A system for supplying AC driving voltages to a plurality of electric motors, wherein said plurality of electric motors comprise a main electric motor, one or more additional electric motors, and a variable voltage source associated with each phase of said main motor, wherein with each phase of each of said one or more additional electric motors a plurality of switches is associated, which are controllable for selectively acquiring a neutral switching state and at least one of a positive parallel switching state, and a positive serial switching state.

Abstract: The invention generally relates to methods and compositions for the prediction of therapeutic efficacy of cancer treatments and the prognosis of cancer. The invention discloses markers that are associated with favorable and unfavorable outcomes, respectively, in certain cancer treatments and are useful as prognostic markers for cancer. Methods involving these markers are disclosed for predicting cancer therapy benefit and prognosing clinical outcome for cancer patients.

Abstract: The invention relates to a method for the two-position control of an actuator (1) on the basis of a binary sensor signal (y) of a sensor unit (2), which senses a process variable (P), which can be influenced by the actuator (1), in such a way that the sensor unit outputs a first sensor signal value (y1) when a first switching value (Sw1) is exceeded and a second sensor signal value (y0) when a second switching value (Sw1, Sw2) is fallen below, wherein: the actuator (1) is controlled with a manipulated variable (u), which assumes either a first control value (u1) or a second control value (u2); the first control value (u1) and the second control value (u2) are dynamically adapted during the operation of the actuator (1), in dependence on a fall time (t_fall) corresponding to the duration of the first sensor signal value (y1) and a rise time (t_rise) corresponding to the duration of the second sensor signal value (y0), in such a way that the first and second control values converge.

Abstract: The present invention proposes an optical band-pass filter with blocked sidebands. The filter comprises a photonic crystal structure based on macroporous silicon having a series of pores defined in the structure. The photonic crystal structure includes a resonator block (BR), comprising at least two periodicity groups (GR1, GR2) between which there is a resonant cavity (CR), wherein the resonant cavity (CR) is adapted to provide a resonance peak in the center of a non-transmitting frequency band of the resonator block (BR); and at least one of a high-pass block (BPA), adapted to block wavelengths below said non-transmitting frequency band; or a low-pass block (BPB), adapted to block wavelengths above said non-transmitting frequency band.

Abstract: Methods are disclosed for a RDMS to compile an SQL assertion into SQL statements. RDMS includes SQL assertions including an SQL assertion to be checked and relational tables fulfilling pre-update satisfaction of the SQL assertions. SQL update and SQL assertion affect relational tables having pre-update content. The methods include: creating triggers to simulate, at run-time, SQL update execution by providing prospective tables with differential content according to SQL update without altering the pre-update content of affected tables; converting the SQL assertion into SQL views to determine, at run-time, satisfaction or dissatisfaction of the SQL assertion depending on pre-update content of affected tables and differential content of prospective tables; and creating a procedure configured to commit or abort, at run-time, SQL update execution onto affected tables depending on whether SQL assertion has been determined satisfied or dissatisfied.

Abstract: Production method for modified lignocellulose materials. The present invention relates to a production method for modified lignocellulose materials, comprising the impregnation of a lignocellulose material, especially wood, with a solution of an acid and an alcohol as well as treatment of the material with superheated steam at elevated temperatures.

Abstract: The present invention provides methods of determining a survival predictor score of a subject having mantle cell lymphoma (MCL). The present invention also provides methods of predicting the survival outcome of a subject having MCL and provides methods of selecting a treatment for a subject having MCL.

Abstract: The invention provides an siRNA against protein S for use in a method of treatment of hemophilia. Also within the scope of the present invention is a method for treating hemophilia in a patient in need thereof, comprising administering to the patient a molecule comprising a siRNA according to the invention, and a dosage form for the prevention or treatment of hemophilia, comprising a molecule comprising a siRNA according to the invention.

Abstract: The present disclosure relates to the use of alkali metal salts and preferably lithium chloride for treatment of Varroa destructor infestation of honey bees.

Abstract: The present invention relates to CXCR6-transduced (a) T cell(s) such as (a) CD8+ T cell(s), (a) CD4+ T cell(s), (a) CD3+ T cell(s), (a) ?? T cell(s) or (a) natural killer (NK) T cell(s) for targeted tumor therapy, nucleic acid sequences, vectors capable of transducing such (a) T cell(s), (a) transduced T cell(s) carrying the nucleic acid sequences or vectors of the present invention, methods and kits comprising the nucleic acid sequences or vectors of the present invention. The invention also provides the use of said transduced T cell(s) in a method for the treatment of diseases characterized by CXCL16 overexpression as well as a pharmaceutical composition/medicament comprising (a) transduced T cell(s) expressing the CXCR6 for use in methods of treating diseases characterized by CXCL16 overexpression.

Abstract: The present invention relates to a mutant ion channel capable of being activated by light (‘light-activated’ ion channel) and having improved properties, nucleic acids and expression vectors encoding the mutant ion channel, cells comprising such nucleic acid or expression vector, devices containing the mutant ion channel, nucleic acid or expression vector as well as respective uses and methods.

Abstract: The present invention relates to a method for detecting a nucleic acid construct or part thereof and/or for detecting the expression product of the nucleic acid construct or part thereof, wherein the method comprises inserting a nucleic acid construct or part thereof into an intron or a synthetic intron, wherein the nucleic acid construct comprises certain defined structures according to the present invention. The present invention also relates to the various uses of the method described herein, to the nucleic acid construct, a vector comprising said nucleic acid construct, a cell comprising said nucleic acid construct and/or said vector, and a respective kit.

Abstract: An embodiment of the invention relates to a sensor comprising a sensor element (10) for measuring a magnetic field, the sensor element (10) comprising a set of at least two first input ports (I1), a set of at least two exit ports (E) each of which is connected to one of the first input ports (I1) via a corresponding first beam path (B1), a set of at least two second input ports (I2) each of which is connected to a second beam path (B2), wherein the first beam paths (B1) extend through a common plane (CP) located inside the sensor element (10), said plane (CP) comprising a plurality of magneto-optically responsive defect centers, wherein the second beam paths (B2) also extend through said common plane (CP), but are angled with respect to the first beam paths (B1) such that a plurality of intersections between the first and second beam paths (B2) is defined, and wherein each intersection forms a sensor pixel (P) located at at least one of said magneto-optically responsive defect centers.

Abstract: The invention relates to a method for preparing polybenzimidazoles of formula (1) or (2) below, wherein n is ?2: by polycondensation of corresponding dicarboxylic acids or dialdehydes and tetraamines by jointly heating the reactants, characterized in that the preparation of polybenzimidazoles of formula (1) or (2) is carried out by using the dialdehydes as starting material and substantially without the formation of any intermediates, wherein a) first, the dialdehyde and the tetraamine are mixed in water at room temperature, which results in the formation of a polyimine by-product; whereafter b) polycondensation is carried out under hydrothermal conditions by heating, in water as a solvent and under pressure, to temperatures above 100° C.

Abstract: The invention relates to oral pharmaceutical compositions of an active agent and a lipid conjugate of a cell penetrating peptide conjugated to a lipid molecule. The conjugated lipid acts as a permeation enhancer for the active agent in the composition. In other words, oral bioavailability of the active agent increases when co-administered together with the lipid conjugate described herein.

Abstract: Medical training model having at least one blood vessel model (1) which in at least one practice region can be connected to an anatomically replicated substitute blood circulation system (2) and in which a real instrument (17) is used, further having an image recording device (3) for creating measured images of the at least one blood vessel model (1), and having an image processing device (11) which converts the recorded measured images into an imaging blood vessel representation and makes same displayable on a screen (12), wherein the image recording device (3) is designed as a photo-optical system (8) which records transmitted-light images (13) as measured images of the at least one blood vessel model (1) for simulation of medical activity, for which purpose the at least one blood vessel model (1) is replicated in a transparently produced solid-bdy block (4) for a contrast between transparent solid-body block (4) and non-transparent instrument (17).

Abstract: The invention relates to a crystal growing unit comprising a crucible for producing and/or enlarging a single crystal. The crystal growing unit has a first thermal insulation with a first thermal conductivity and a second thermal insulation with a second thermal conductivity. The crucible has a crucible base, a crucible side wall and a crucible cover. The crucible side wall is indirectly or directly surrounded by the first thermal insulation. The second thermal insulation is arranged indirectly or directly above the crucible cover. The second thermal conductivity is greater than the first thermal conductivity.